Similar articles

• Quinupristin-dalfopristin use in children is associated with arthralgias and myalgias.

  Gupte G, Jyothi S, Beath SV, Kelly DA. Gupte G, et al. Pediatr Infect Dis J. 2006 Mar;25(3):281. doi: 10.1097/01.inf.0000208571.61283.ea. Pediatr Infect Dis J. 2006. PMID: 16511403 No abstract available.
• Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal.

  Johnson AP, Livermore DM. Johnson AP, et al. Lancet. 1999 Dec 11;354(9195):2012-3. doi: 10.1016/s0140-6736(99)00344-x. Lancet. 1999. PMID: 10636359 No abstract available.
• Use of virginiamycin as a growth promoter.

  Barrow PA. Barrow PA. Vet Rec. 1998 Oct 24;143(17):483-4. Vet Rec. 1998. PMID: 9829311 No abstract available.
• Occurrence and epidemiology of resistance to virginiamycin and streptogramins.

  Thal LA, Zervos MJ. Thal LA, et al. J Antimicrob Chemother. 1999 Feb;43(2):171-6. doi: 10.1093/jac/43.2.171. J Antimicrob Chemother. 1999. PMID: 11252321 Review. No abstract available.
• [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].

  Klare I, Witte W. Klare I, et al. Wien Klin Wochenschr. 1997 May 9;109(9):293-300. Wien Klin Wochenschr. 1997. PMID: 9265387 Review. German. No abstract available.